118 related articles for article (PubMed ID: 31182687)
1. Anchored Fibromodulin as a Novel Target in Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications.
Farahi L; Ghaemimanesh F; Milani S; Razavi SM; Hadavi R; Bayat AA; Salimi A; Akhondi MM; Rabbani H
Iran J Immunol; 2019 Jun; 16(2):127-141. PubMed ID: 31182687
[TBL] [Abstract][Full Text] [Related]
2. FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study.
Sorigue M; Junca J; Ferra C; Marce S; Ruiz-Xivillé N; Pinyol L; Cabezon M; Espasa A; Dominguez D; Lopez-Viaplana L; Ruiz R; Buch J; Plensa E; Mostacedo SZ; Aranda J; Vergara S; Raya M; Granada I; Tapia G; Navarro JT; Beà S; Zamora L
Cytometry B Clin Cytom; 2020 Sep; 98(5):421-428. PubMed ID: 32530577
[TBL] [Abstract][Full Text] [Related]
3. A novel ADC targeting cell surface fibromodulin in a mouse model of triple-negative breast cancer.
Haji Ghaffari M; Simonian M; Salimi A; Mirzadegan E; Sadeghi N; Nejadmoghaddam MR; Ebrahimnezhad N; Fazli G; Fatemi R; Bayat AA; Mazloomi M; Rabbani H
Breast Cancer; 2022 Nov; 29(6):1121-1132. PubMed ID: 35982394
[TBL] [Abstract][Full Text] [Related]
4. Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes.
Mayr C; Bund D; Schlee M; Moosmann A; Kofler DM; Hallek M; Wendtner CM
Blood; 2005 Feb; 105(4):1566-73. PubMed ID: 15471955
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal and Polyclonal Antibodies Specific to Human Fibromodulin.
Farahi L; Ghaemimanesh F; Milani S; Razavi SM; Bayat AA; Rabbani H; Akhondi MM
Iran J Biotechnol; 2019 Jan; 17(1):e2277. PubMed ID: 31457049
[TBL] [Abstract][Full Text] [Related]
6. A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes.
McCarthy BA; Yancopoulos S; Tipping M; Yan XJ; Wang XP; Bennett F; Li W; Lesser M; Paul S; Boyle E; Moreno C; Catera R; Messmer BT; Cutrona G; Ferrarini M; Kolitz JE; Allen SL; Rai KR; Rawstron AC; Chiorazzi N
Immunol Res; 2015 Dec; 63(1-3):90-100. PubMed ID: 26318878
[TBL] [Abstract][Full Text] [Related]
7. Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells.
Choudhury A; Derkow K; Daneshmanesh AH; Mikaelsson E; Kiaii S; Kokhaei P; Osterborg A; Mellstedt H
Br J Haematol; 2010 Nov; 151(4):327-35. PubMed ID: 20813009
[TBL] [Abstract][Full Text] [Related]
8. The Association of Cell Surface Fibromodulin Expression and Bladder Carcinoma.
Bayat AA; Sadeghi N; Salimi A; Fazli G; Nowroozi MR; Ohadian Moghadam S; Radmanesh A; Tabasi M; Sarrafzadeh AR; Zarei O; Rabbani H
Urol J; 2021 Jul; 19(3):189-195. PubMed ID: 34247360
[TBL] [Abstract][Full Text] [Related]
9. Identification of a global gene expression signature of B-chronic lymphocytic leukemia.
Jelinek DF; Tschumper RC; Stolovitzky GA; Iturria SJ; Tu Y; Lepre J; Shah N; Kay NE
Mol Cancer Res; 2003 Mar; 1(5):346-61. PubMed ID: 12651908
[TBL] [Abstract][Full Text] [Related]
10. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
11. Study of fibromodulin gene expression in B-cell chronic lymphocytic leukemia.
Hassan DA; Samy RM; Abd-Elrahim OT; Salib CS
J Egypt Natl Canc Inst; 2011 Mar; 23(1):11-5. PubMed ID: 22099931
[TBL] [Abstract][Full Text] [Related]
12. Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia.
Giannopoulos K; Li L; Bojarska-Junak A; Rolinski J; Dmoszynska A; Hus I; Greiner J; Renner C; Döhner H; Schmitt M
Int J Oncol; 2006 Jul; 29(1):95-103. PubMed ID: 16773189
[TBL] [Abstract][Full Text] [Related]
13. Sortilin as a Novel Diagnostic and Therapeutic Biomarker in Chronic Lymphocytic Leukemia.
Farahi L; Ghaemimanesh F; Milani S; Razavi SM; Akhondi MM; Rabbani H
Avicenna J Med Biotechnol; 2019; 11(4):270-276. PubMed ID: 31908734
[TBL] [Abstract][Full Text] [Related]
14. Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL).
Uhrmacher S; Schmidt C; Erdfelder F; Poll-Wolbeck SJ; Gehrke I; Hallek M; Kreuzer KA
Leuk Res; 2011 Oct; 35(10):1360-6. PubMed ID: 21531460
[TBL] [Abstract][Full Text] [Related]
15. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia.
Uckun FM; Fauci AS; Chandan-Langlie M; Myers DE; Ambrus JL
J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271
[TBL] [Abstract][Full Text] [Related]
16. A proline/arginine-rich end leucine-rich repeat protein (PRELP) variant is uniquely expressed in chronic lymphocytic leukemia cells.
Mikaelsson E; Österborg A; Jeddi-Tehrani M; Kokhaei P; Ostadkarampour M; Hadavi R; Gholamin M; Akhondi M; Shokri F; Rabbani H; Mellstedt H
PLoS One; 2013; 8(6):e67601. PubMed ID: 23826326
[TBL] [Abstract][Full Text] [Related]
17. Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia.
Cyr MG; Mhibik M; Qi J; Peng H; Chang J; Gaglione EM; Eik D; Herrick J; Venables T; Novick SJ; Courouble VV; Griffin PR; Wiestner A; Rader C
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36442911
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M
Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974
[TBL] [Abstract][Full Text] [Related]
19. Catabolism of Fibromodulin in Developmental Rudiment and Pathologic Articular Cartilage Demonstrates Novel Roles for MMP-13 and ADAMTS-4 in C-terminal Processing of SLRPs.
Shu CC; Flannery CR; Little CB; Melrose J
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30700002
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]